Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
8 papers
This systematic review looked at 17 studies with a total of 603 participants on ketamine-assisted psychotherapy (KAP). The reviewed reports say KAP can, in some cases, start and lengthen meaningful reductions in pain, anxiety, and depression, and help with rapport, treatment engagement, and abstinence for people with substance problems. However,…
This review looked at research on exercise addiction from 2010 to 2022. It says there are over 1,000 papers, but exercise addiction is not a formal clinical diagnosis. Many studies use scales and questionnaires that mix up true addiction with high commitment or exercise used for other problems (like eating…
This paper reviews couple therapy in the 2020s. It says couple therapy has become a main way to help couples and is grounded in strong research from studies of couple therapy and relational science. The review reports that couple therapy is widely accepted for reducing relationship distress and improving relationship…
Maternity blues, also called baby blues, are short-lived mood changes after childbirth that can include tearfulness, irritability, anxiety, sleep and concentration problems. A recent review reports an overall prevalence of about 39% (studies ranged from 13.7% to 76%), but definitions and measurements vary widely. Symptoms usually start in the first…
This narrative review summarizes what is known about eating disorders, focusing on anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED). The authors say these conditions often start in adolescence or early adulthood, are diagnosed more often in young women, and can harm physical, mental, and social health.…
This review describes a rapid rise in medical research on psychedelic drugs over the past five years. Several later-stage clinical trials have been published, and many different drugs — including psilocybin, MDMA, ketamine, LSD, ayahuasca, and ibogaine — are being tested for conditions such as depression, post‑traumatic stress, addiction, obsessive‑compulsive…
This paper reviews what is known about “medical gaslighting,” especially in gastroenterology. The authors found no studies that directly measure gaslighting in chronic digestive diseases, so they drew on related research about gaslighting, doctor–patient communication, burnout, and stigma. They propose the new term “medical invalidation” to cover situations where a…
SPRAVATO (esketamine) is a prescription nasal spray for adults with treatment‑resistant depression to be used together with an oral antidepressant. It must be given and watched by a healthcare provider because it can cause sedation, dissociation, and increases in blood pressure. Patients are observed for at least two hours after…
